| |
|
|
|
Hemispherx Biopharma  
|
|
0.345 0.012 (0.04%) |
04-24 12:05 |
|
Open: |
0.335 |
Pre close: |
0.355 |
Target:
|
0.52
|
|
High: |
0.3631 |
Low: |
0.3215 |
Resistance:
|
0.44
0.52
|
|
Volume: |
554,822 |
Market Cap: |
16M |
Support:
|
0.32
0.27
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.36
 |
MACD |
MACD(12,26):
|
-0.03 |
|
MA(20): |
0.40 |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
0.43 |
Stochastic Oscillator |
%K(14,3):
|
9.76  |
|
MA(250): |
0.43 |
%D(3): |
7.24 |
|
Average Volume(K) |
3-Month: |
42678
|
52-Week |
High:
|
0.74 |
|
10-Days: |
43118 |
Low: |
0.30 |
|
RSI |
RSI(14):
|
33.72 |
Change(%): |
-50.7 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-68.3 |
Shares Out. (M) |
37.72 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-49.9 |
Shares Float (M) |
34.33 |
|
EPS Est. Next Year |
-0.030 |
PEG Ratio |
0.00 |
% Held by Insiders |
10.60 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
212.5 |
% Held by Institutions |
8.40 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1152 |
|
Book Value (p.s.) |
1.650 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.21 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-7.94 |
P/S |
1282857088.00 |
|
Operating Margin |
-2610.75 |
Levered Free Cash Flow
(M) |
-5.73 |
P/CF |
-1.62 |
|
|
|
|
|
|
